Abiraterone 500mg tablets
NHS hospitals in England used £116,972,778 of indicative cost of Abiraterone 500mg tablets in the 12 months to April 2026, about 0.5% of all hospital medicines spend. That is up 30.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Abiraterone 500mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Abiraterone 500mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £8,164,643 |
| The Clatterbridge Cancer Centre Nhs Ft | £6,014,991 |
| South Tyneside And Sunderland Nhs Ft | £5,751,274 |
| University Hospitals Plymouth Nhs Trust | £5,604,850 |
| The Royal Marsden Nhs Foundation Trust | £4,926,425 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £4,810,414 |
| Southend Univ Hosp Nhs Foundation Trust | £3,980,535 |
| Nottingham University Hospitals Trust | £2,893,388 |
| Royal Surrey County Hosp Nhs Found Trust | £2,742,210 |
| University Hospital Southampton Nhs Ft | £2,587,919 |
The primary-care picture
Abiraterone is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Abiraterone medicine page.